Metabolic alkalosis - Nephkids
Transcript of Metabolic alkalosis - Nephkids
Metabolic alkalosis
Dr N C GowrishankarMD DCH DNB FIAP
Pediatric Pulmonologist &Head-Pediatrics:Clinical Operations &Quality
Mehta Multispeciality Hospitals India Pvt Ltd, Chennai
Scope
• Basics
• Causes
• Pathophysiology
• Clinical features
• Investigations
• Management algorithm
12/6/2020 2NCGS metabolic alkalosis
Basics
• Normal pH - 7.35 to 7.45• CO2 levels regulated – Lungs : HCO3 levels regulated –kidneys• Arterial blood gas – normal values :
– pH - 7.35 to 7.45– HCO3 - 21 to 27 mEq/L– PCO2 - 35 to 45 mmHg
• Alkalemia – An arterial pH above normal range (greater than 7.45)• Alkalosis – A process that tends to raise extracellular fluid pH-
elevation serum HCO3 concentration and/or fall in PCO2 - Alkalosis is not necessarily accompanied by alkalemia
12/6/2020 3NCGS metabolic alkalosis
Metabolic alkalosis
• A disorder -elevates serum HCO3 concentration and pH
• pH > 7.45• HCO3- > 28 mmol/l• Kidney normally respond -
rapidly excrete excess alkali • Only when additional factor
disrupts renal regulation of body alkali stores- Sustained metabolic alkalosis
3 months - 2011 March – CF
12/6/2020 4NCGS metabolic alkalosis
Systemic pH- Chemoreceptors
• Central (ventrolateral surface-medulla oblongata )-sensitive to pH
• Peripheral (carotid & aortic bodies) -detect variation -arterial PCO2 & as well as arterial PO2
• Chemoreceptors - lead to adjustments -both components of minute ventilation: tidal volume & respiratory cycle frequency (through central respiratory control centers in pons and medulla)
• Lung-mediated changes in arterial PCO2 -rapid alteration in systemic hydrogen ions (H+) - CO2 lipid soluble - readily cross cell membranes -allow tight control of arterial PCO2 near 40 mm Hg
12/6/2020 5NCGS metabolic alkalosis
Kidney role in acid base balance
• Reabsorbing filtered HCO3 & excreting daily acid load derived – metabolism – sulfur containing amino acids
• Filtered HCO3
– 90% - reabsorbed - proximal tubules –primarily by Na-H exchange
– Remaining 10% -reabsorbed - distal nephron - primarily via hydrogen secretion by proton pump (H-ATPase)
• Under normal conditions - no HCO3 present in final urine.
12/6/2020 6NCGS metabolic alkalosis
Cellular and luminal event – bicarbonate reabsorbtion-Proximal convoluted tubule
Na + K + ATPase – create steep electrochemical gradient for Na+
H + secreted into lumen in exchange for Na + by Na + H + exchanger
12/6/2020 7NCGS metabolic alkalosis
Cellular and luminal event – bicarbonate reabsorbtion-Proximal convoluted tubule
H+ entering lumen – combine with filtered HCO3-
form H2CO3- dissociated by carbonic anhydrase IV tethered to membrane- H2O & CO2- passively reabsorbed
Peritubularcapillary Proximal Tubular cell Tubular lumen
CO2 combines with OH- – form HCO3-
(carbonic anhydrase II) – enter peritubular capillary by Na+ 3HCO3- cotransporter
90% filtered HCO3 reclaimed
12/6/2020 8NCGS metabolic alkalosis
Kidney role in acid base balance
• Reabsorbing filtered HCO3 & excreting daily acid load derived – metabolism – sulfur containing amino acids
• Filtered HCO3
– 90% - reabsorbed - proximal tubules –primarily by Na-H exchange
– Remaining 10% -reabsorbed - distal nephron - primarily via hydrogen secretion by proton pump (H-ATPase)
• Under normal conditions - no HCO3 present in final urine.
12/6/2020 9NCGS metabolic alkalosis
Type A cell-Distal convoluted & collecting tubule
10% filtered HCO3- enter distal tubule-Combine with H+ form H2CO3-
Dissociate- H2O & CO2- passively reabsorbed into cell
H+ATPase pump- drive H+ secretion
cellular HCO3- moves into peritubular capillary in exchange for extracellular chloride by
Cl-HCO3- exchanger
12/6/2020 10NCGS metabolic alkalosis
H+K+ATPase – luminal membrane- promote H+ secretion & K+ absorbtion
Type A cell-Distal convoluted & collecting tubule
Excretion of daily H+ load - occur distal tubule -H+ must be bound to buffer to avoid excessive urine acidification Kidneys synthesize and excrete NH3 - which combines with H+ - form NH4 +
12/6/2020 11NCGS metabolic alkalosis
Metabolic alkalosis
• Elevation- plasma HCO3- Several mechanisms – Excessive hydrogen loss– Functional addition of new HCO3– Volume contraction around a relatively constant amount of
extracellular HCO3 - “contraction alkalosis”• Kidneys
– Extremely efficient in eliminating excess HCO3 in urine
12/6/2020 12NCGS metabolic alkalosis
Addition of HCO3
• Decreased renal excretion of HCO3(Renal failure )
• Posthypercapnic alkalosis
• Excessive intake / very large quantities of HCO3 administered acutely
• Administration - large quantities >8 units citrated blood product infusion / fresh frozen plasma (citrate converted to bicarbonate by liver)
Contraction alkalosis • IV loop diuretics – fluid loss without bicarbonate• Disorders – high Cl & low HCO3 solution lost– Sweat losses in cystic fibrosis– Loss of gastric secretions in achlorhydria– Fluid loss from frequent stools- congenital
chloridorrhea/ villous adenoma• BPD - chronic respiratory acidosis - receive diuretics – further ↓intravascular volume
• Posthypercapnic alkalosis Chronic respiratory acidosis – compensatory ↑H+ secretion & ensuing ↑ in HCO3 Reduce PCO2 gradually by mechanical ventilation – if PCO2 decreased rapidly -
ensuing metabolic alkalosis - slow to disappear
12/6/2020 13NCGS metabolic alkalosis
Kidneys promptly respond to metabolic alkalosis –
increasing base excretion
For generation of metabolic alkalosis- addition of
base/loss of acid to body required
For maintenance of metabolic alkalosis –
impairment - kidney's ability to excrete base required
12/6/2020 14NCGS metabolic alkalosis
Maintenance phase of metabolic alkalosis
normal renal response to metabolic alkalosis –
urinary loss of bicarbonate
Volume depletion interferes with urinary loss of bicarbonate -
3 mechanisms
Reduction in GFR, so less bicarbonate filtered
↑angiotensin II & ↑adrenergic stimulation of kidney -
Increased reabsorption – Na+ & HCO3- in PCT - limit HCO3 that
can be excreted in urine
↑aldosterone -increases HCO3-
reabsorption & H+ secretion in collecting duct
caused by volume depletion (“chloride depletion” from gastric loss of HCl)
12/6/2020 15NCGS metabolic alkalosis
12/6/2020 NCGS metabolic alkalosis 16
Chloride resistant
Normal Blood Pressure High Blood Pressure
Bartter syndromeGitelman syndrome Autosomal dominant
hypoparathyroidismEAST syndromeBase administration
Cushing syndromeAdrenal adenoma/
hyperplasiaGlucocorticoid-remediable
aldosteronismRenovascular diseaseRenin-secreting tumor17α-Hydroxylase deficiency11β-Hydroxylase deficiency11β-Hydroxysteroid dehydro
genase deficiency Licorice ingestionLiddle syndrome
Chloride responsive
Gastric lossesEmesisNasogastric suctionDiuretics (loop or thiazide)Cystic fibrosis Chloride-losing diarrhea Post hypercapniaLow chloride formula
Metabolic alkalosis - Classification – based on response to chloride
Bartter & Gitelman syndromes
• Metabolic alkalosis & hypokalemia• Genetic defect - transporters
• Gitelman syndrome : Na-Cl cotransporter – distal tubule -same location as those inhibited by thiazidediuretics
• Bartter syndrome: Na-K-2Cl cotransporter- loop of Henle- same location as those inhibited by loop diuretics
12/6/2020 17NCGS metabolic alkalosis
Consequences of Untreated Alkalosis
System Effects
Cerebral •Cerebral vasoconstriction with reduction of cerebral blood flow•Tetany, seizures, lethargy, delirium, stupor
Cardiovascular •Vasoconstriction - small arterioles, including coronary arteries •Decreased threshold for arrhythmias
Respiratory •Compensatory hypoventilation with possible subsequent hypoxemia & hypercarbia
Hematologic •Oxyhemoglobin dissociation curve shifts to left
Metabolic & Electrolyte Imbalances
•Stimulation of anaerobic glycolysis•Hypokalemia•Decreased plasma ionized calcium •Hypomagnesemia and hypophosphatemia
12/6/2020 18NCGS metabolic alkalosis
Clinical features
• Features directly related to metabolic alkalosis uncommon• Asymptomatic: alterations in blood HCO3 concentration –
slow → less pronounced change in intracellular pH & brain pH• Symptoms primarily related to
– Alkalemia– Underlying etiology of metabolic alkalosis– Accompanying electrolyte abnormalities
12/6/2020 19NCGS metabolic alkalosis
Clinical features• Alkalemia –
– ↓ ionised Ca+ - ↑binding of calcium to albumin - symptoms of tetany
– ↓decrease cardiac output – Shift K+ intracellularly - decrease in extracellular K+ -
hypokalemia - muscle weakness, cardiac arrhythmias• Metabolic alkalosis
– compensatory ↑ in PCO2 decreasing ventilation -if underlying lung disease -hypoxia.
– With normal lungs, severe metabolic alkalosis can cause hypoxia
12/6/2020 20NCGS metabolic alkalosis
Clinical features
• If metabolic alkalosis from vomiting – symptoms of severe volume contraction– signs of dehydration - tachycardia, dry mucous
membranes, decreased skin turgor, postural hypotension, poor peripheral perfusion, weight loss.
• Children with congenital chloride –watery diarrhea at birth, metabolic alkalosis, hypovolemia.
• Weight gain &hypertension - ↑mineralocorticoid state.
12/6/2020 NCGS metabolic alkalosis 21
Diagnosis
• History
• Clinical exam – rarely gives clue to diagnosis
• Investigations
– Arterial blood gas
– Serum electrolytes
– Spot urine chloride measurements
12/6/2020 22NCGS metabolic alkalosis
Investigations
• ABG: elevated pH - high bicarbonate (HCO3) level - with compensation, PCO2 may be near reference range/ elevated.
• Serum electrolytes: hypokalemia, hypochloremia, hyponatremia
• Urine chloride – < 20 mEq/L - chloride-responsive metabolic alkalosis– > 20 mEq/L - chloride-resistant metabolic alkalosis
12/6/2020 NCGS metabolic alkalosis 23
Appropriate Compensation
• Metabolic alkalosis - appropriate respiratory compensation - by decreasing ventilation
• Should raise PCO2 by approximately 0.7 mmHg for every 1 mEq/L elevation in serum HCO3 concentration
• PCO2 appropriately increased or not :easy to use
• PCO2 = HCO3 + 10
• If PCO2
– Lower than expected compensation- concurrent respiratory alkalosis
– Greater than expected compensation - concurrent respiratory acidosis
• Respiratory compensation never exceeds PCO2 of 55-60 mm Hg
12/6/2020 NCGS metabolic alkalosis 24
Treatment
• Address underlying disease state
• Goal
– prevent life-threatening complications with least amount of correction -target pH & bicarbonate levels (correcting severe alkalemia)
• Hypovolemia
– Intravascular volume expansion - isotonic crystalloid solution(Isotonic saline) – under close monitoring
• Diuretics
– if change tolerated- dose reduced/ eliminated
12/6/2020 NCGS metabolic alkalosis 25
Treatment – moderate/severe metabolic alkalosis
• Reducing H+ loss– Nasogastric suction –discontinue /Replace NG aspirate equivalent
promptly –avoid volume loss
– Proton pump inhibitor - ↓ gastric secretion –reduces loss of HCl
• Correcting K+ -Potassium– Adequate K+ supplementation as chloride salt - also help replenish
chloride losses partly
– K+ sparing diuretic use : decrease renal K+ loss
12/6/2020 26NCGS metabolic alkalosis
Treatment - moderate or severe metabolic alkalosis
• Increasing HCO3 excretion
– K+ sparing diuretic use - block action of aldosterone → decrease H+
secretion in distal nephron – facilitate ↑HCO3 excretion– Acetazolamide (carbonic anhydrase inhibitor)
• ↓ HCO3 − resorption in PCT - significant bicarbonate loss in urine• Produces major K+ losses - urine • ↑ fluid losses - necessitating dose reduction -other diuretics
• Arginine HCl - chloride-responsive metabolic acidosis if sodium or potassium salts are not appropriate - may raise serum K+ levels during administration
12/6/2020 27NCGS metabolic alkalosis
Treatment- chloride-responsive
• Most metabolic alkalosis → Cl responsive etiology
• Sufficient NaCl & KCl administration
– Correct volume deficit & potassium deficit
– Not an option if volume depletion due to diuretics as volume repletion may be contraindicated.
• With adequate intravascular volume & normal serum K + - kidney excretes excess bicarbonate within 2 days
12/6/2020 28NCGS metabolic alkalosis
Renovascular disease – surgical correction
17α hydroxylase deficiency/11β-hydroxylase deficiency - glucocorticoid
11β-hydroxysteroid dehydrogenase deficiency – spironolactone –decrease mineralocorticoid effect of cortisol
Bartter or Gitelman syndrome –oral Na+ & K+ supplementation +/- potassium-sparing diuretics
Gitelman syndrome –Mg supplementation
Adrenal adenomas –resection
Treatment- chloride-resistant
12/6/2020 29NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
12/6/2020 30NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
12/6/2020 31NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
BP normal BP high
12/6/2020 32NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
BP normal BP high
Ongoing diureticsBartter syndromeGitelman syndromeHypokalemiaHypomagnesemia
12/6/2020 33NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
BP normal BP high
Ongoing diureticsBartter syndromeGitelman syndromeHypokalemiaHypomagnesemia
High renin Low renin
12/6/2020 34NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
BP normal BP high
Ongoing diureticsBarrter syndromeGitelman syndromeHypokalemiaHypomagnesemia
High renin Low renin
Ongoing diureticsRenal A stenosisRenin sec tumor
12/6/2020 35NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
BP normal BP high
Ongoing diureticsBarrter syndromeGitelman syndromeHypokalemiaHypomagnesemia
High renin Low renin
Ongoing diureticsRenal A stenosisRenin sec tumor
Aldosteronelevel
12/6/2020 36NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
BP normal BP high
Ongoing diureticsBarrter syndromeGitelman syndromeHypokalemiaHypomagnesemia
High renin Low renin
Ongoing diureticsRenal A stenosisRenin sec tumor
Aldosteronelevel
Low High
12/6/2020 37NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
BP normal BP high
Ongoing diureticsBarrter syndromeGitelman syndromeHypokalemiaHypomagnesemia
High renin Low renin
Ongoing diureticsRenal A stenosisRenin sec tumor
Aldosteronelevel
Low High
Cushing syndromeCS use17hydroxylase defLiddle syndrome12/6/2020 38NCGS metabolic alkalosis
Metabolic alkalosis – Suggestive history/ABG/electrolytes
Urine chloride level > 20 mmol/L< 20 mmol/L
Recent diuretic therapyGastric lossPost hypercapnic stateVillous adenoma
BP normal BP high
Ongoing diureticsBarrter syndromeGitelman syndromeHypokalemiaHypomagnesemia
High renin Low renin
Ongoing diureticsRenal A stenosisRenin sec tumor
Aldosteronelevel
Low High
Cushing syndromeCS use17hydroxylase defLiddle syndrome
HyperaldosteronismAdrenal adenomaAdrenal hyperplasia
12/6/2020 39NCGS metabolic alkalosis
Thank you
12/6/2020 NCGS metabolic alkalosis 40